| 抗新冠肺炎中药连花清瘟胶囊化学成分与临床功效研究进展 |
| |
| 引用本文： | 曾垣烨,何盈盈,唐庆龙,李康,顾妍秋,陈啸飞.抗新冠肺炎中药连花清瘟胶囊化学成分与临床功效研究进展[J].药学实践杂志,2021,39(4):291-294,361. |
| |
| 作者姓名： | 曾垣烨 何盈盈 唐庆龙 李康 顾妍秋 陈啸飞 |
| |
| 作者单位： | 海军军医大学药学院，上海 200433;军委政治工作部原机关门诊部，北京 100120;南部战区总医院卫勤部，广东 广州 510010;上海交通大学医学院附属第九人民医院，上海 201999 |
| |
| 基金项目： | 国家自然科学基金项目（81973275、82003909）；上海市科学技术委员会项目（19QA1411500） |
| |
| 摘 要： | 新型冠状病毒肺炎(COVID-19)疫情的爆发对人类健康与社会稳定造成了巨大威胁.随着病毒在全球迅速蔓延,针对新型冠状病毒(SARS-CoV-2)的药物开发及其相关研究成为医学领域的迫切问题.COVID-19归入中医学理论中的疫病范畴,连花清瘟胶囊(颗粒)屡次在重大疫情中发挥重要作用.既往研究表明,连花清瘟胶囊可能抑制...
|
| 关 键 词： | 新型冠状病毒肺炎 连花清瘟胶囊 药理活性 |
| 收稿时间： | 2020/11/2 0:00:00 |
| 修稿时间： | 2021/5/16 0:00:00 |
Research progress on chemical composition and clinical efficacy of Lianhua Qingwen (LHQW) capsule, a traditional Chinese medicine (TCM) used to treat COVID-19 |
| |
| ZENG Yuanye,HE Yingying,TANG Qinglong,LI Kang,GU Yanqiu,CHEN Xiaofei.Research progress on chemical composition and clinical efficacy of Lianhua Qingwen (LHQW) capsule, a traditional Chinese medicine (TCM) used to treat COVID-19[J].The Journal of Pharmaceutical Practice,2021,39(4):291-294,361. |
| |
| Authors: | ZENG Yuanye HE Yingying TANG Qinglong LI Kang GU Yanqiu CHEN Xiaofei |
| |
| Institution: | School of Pharmacy, Naval Medical University, Shanghai 200433, China;Former Organ Out-patient Department of Political Work Department of Central Military Commission, Beijing 100120, China;Medical Service Department, General Hospital of Southern Theater Command, Guangzhou 510010, China;Department of Pharmacy, Ninth People''s Hospital Affiliated to Shanghai Jiaotong University, Shanghai 201999, China |
| |
| Abstract: | The outbreak of COVID-19 posed a huge threat to human health and social stability. With the rapid spread of the virus around the world, the drug development and related research of novel coronavirus (SARS-CoV-2) have become an urgent issue in the medical field. COVID-19 fails into the category of epidemics in the theory of TCM. LHQW capsule has repeatedly played an important role in many major epidemics. Previous studies have shown that LHQW capsule can inhibit the biological activity of varied viruses including MERS-CoV and SARS-CoV. The paper summarizes the relevant research data and achievements of LHQW capsule in the past few years, reviews the chemical constituents, clinical efficacy and pharmacological effects of LHQW capsule, and provides scientific basis for the anti-virus mechanism of LHQW capsule and clinical treatment of COVID-19. |
| |
| Keywords: | COVID-19 Lianhua Qingwen capsule pharmacological activity |
|
| 点击此处可从《药学实践杂志》浏览原始摘要信息 |
| 点击此处可从《药学实践杂志》下载免费的PDF全文 |
|
